glp 1 gentle patches GLP-1 Review: Innovation or Illusion? Do GLP-1 Patches Work for
Description
doi: 10.1097/MD.0000000000019762 14 VestergaardP
The pharma giant cites a report from the Brookings Institute that the FDA has never authorized or approved the manufacturing processes used by any of these foreign suppliers to make semaglutide, nor has the FDA ever reviewed or authorized the quality of the "semaglutide" they produce
However, such coverage comes with strict eligibility requirements, such as patients needing an extremely high BMI and associated health conditions
Post-meal pharmacodynamic profile of AVE0010, a once-daily GLP-1 receptor agonist, in patients with type 2 diabetes inadequately controlled on metformin [abstract 131]
PMID 27569426
